Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Apolipoprotein B-100, Familial Defective

1-anilino-8-naphthalenesulfonate has been researched along with Apolipoprotein B-100, Familial Defective in 23 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Research Excerpts

ExcerptRelevanceReference
"In order to compare the effects of lovastatin and probucol on lipoprotein profiles, we treated 32 familial hypercholesterolemia (FH) heterozygotes and 26 patients with non-familial hypercholesterolemia for 14 weeks with either probucol (1 g/d) or lovastatin (40-80 mg/d) in a randomized double-blind study."9.06Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles. ( Helve, E; Tikkanen, MJ, 1988)
"In order to compare the effects of lovastatin and probucol on lipoprotein profiles, we treated 32 familial hypercholesterolemia (FH) heterozygotes and 26 patients with non-familial hypercholesterolemia for 14 weeks with either probucol (1 g/d) or lovastatin (40-80 mg/d) in a randomized double-blind study."5.06Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles. ( Helve, E; Tikkanen, MJ, 1988)
"The genetic cause of familial hypercholesterolemia is unknown in 20%-40% of the cases."2.61Genes Potentially Associated with Familial Hypercholesterolemia. ( Ivanoshchuk, D; Mikhailova, S; Shakhtshneider, E; Timoshchenko, O, 2019)
"To evaluate coronary atherosclerosis, we used CSI (coronary stenosis index) calculated from coronary angiograms."1.33CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia. ( Higashikata, T; Inazu, A; Katsuda, S; Kawashiri, MA; Kobayashi, J; Mabuchi, H; Miwa, K; Nohara, A; Takata, M; Yamagishi, M, 2006)
"Homozygous familial hypercholesterolemia (FH) is a rare genetic disorder that leads to premature atherosclerosis due to a defective LDL receptor."1.30Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia. ( Brewer, HB; Dugi, KA; Feuerstein, IM; Hill, S; Hoeg, JM; Santamarina-Fojo, S; Shih, J, 1997)
"It is concluded that in familial hypercholesterolemia ileal bypass results in higher HDL- and HDL2-cholesterol and apoprotein A-I level than conservative treatment and that postheparin plasma lipolytic enzymes do not explain the higher level of these HDL components in the operated subjects."1.27High density lipoprotein, apoproteins A-I and A-II and postheparin plasma lipolytic enzymes after ileal bypass. ( Koivisto, P; Kuusi, T; Miettinen, TA, 1987)

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19906 (26.09)18.7374
1990's7 (30.43)18.2507
2000's5 (21.74)29.6817
2010's3 (13.04)24.3611
2020's2 (8.70)2.80

Authors

AuthorsStudies
Zhang, H1
Li, FY1
Hao, Y1
Wang, XM1
Zhang, J1
Ma, YL1
Zeng, H1
Lin, J1
Mikhailova, S1
Ivanoshchuk, D1
Timoshchenko, O1
Shakhtshneider, E1
Corral, P1
Bañares, V1
Sáenz, B1
Zago, V1
Sarobe, A1
López, G1
Berg, G1
Schreier, L1
Guay, SP1
Brisson, D1
Lamarche, B1
Gaudet, D1
Bouchard, L1
Tada, H1
Kobayashi, J2
Kawashiri, MA2
Miyashita, K1
Nohara, A2
Inazu, A2
Nakajima, K1
Mabuchi, H2
Yamagishi, M2
Takata, M1
Katsuda, S1
Miwa, K1
Higashikata, T1
August, E1
Parker, KH1
Barahona, M1
Muller, DP1
Gamlen, TR1
Breier, C1
Lisch, HJ1
Drexel, H1
Braunsteiner, H1
Rudel, LL1
Newton, R1
Hamilton, R1
Deckelbaum, RJ1
Hobbs, HH1
Dugi, KA1
Feuerstein, IM1
Hill, S1
Shih, J1
Santamarina-Fojo, S1
Brewer, HB1
Hoeg, JM1
Hirano, K1
Yamashita, S1
Sakai, N1
Matsuzawa, Y1
Elleder, M1
Chlumska, A1
Ledvinová, J1
Poupetová, H1
Wang, J1
Guerra, R1
Cohen, J1
Tada, N1
Yamamoto, A1
Ouguerram, K1
Magot, T1
Lutton, C1
Moriguchi, EH1
Tamachi, H1
Goto, Y1
Kawamura, M1
Iwakami, M1
Naito, C1
Zannis, VI1
Breslow, JL1
Helve, E1
Tikkanen, MJ1
Gavish, D1
Oschry, Y1
Fainaru, M1
Eisenberg, S1
Koivisto, P1
Kuusi, T1
Miettinen, TA1

Reviews

6 reviews available for 1-anilino-8-naphthalenesulfonate and Apolipoprotein B-100, Familial Defective

ArticleYear
Genes Potentially Associated with Familial Hypercholesterolemia.
    Biomolecules, 2019, 11-29, Volume: 9, Issue:12

    Topics: Adaptor Proteins, Signal Transducing; Animals; ATP Binding Cassette Transporter, Subfamily G, Member

2019
[Hyperalphalipoproteinemia].
    Ryoikibetsu shokogun shirizu, 1998, Issue:19 Pt 2

    Topics: Arteriosclerosis; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Glycoprot

1998
[Remnant hyperlipidemia].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 3

    Topics: Apolipoproteins; Cholesterol; Diagnosis, Differential; Humans; Hyperlipidemia, Familial Combined; Hy

2001
[Gene mutations in familial hyperlipidemias].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 2

    Topics: Apolipoproteins E; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hyperlip

2001
Alterations in cholesterol metabolism in the genetically hypercholesterolemic RICO rat: an overview.
    Advances in experimental medicine and biology, 1991, Volume: 285

    Topics: Animals; Apolipoproteins; Cholesterol; Cholesterol Esters; Hyperlipoproteinemia Type II; Lipase; Lip

1991
Genetic mutations affecting human lipoprotein metabolism.
    Advances in human genetics, 1985, Volume: 14

    Topics: Abetalipoproteinemia; Amino Acid Sequence; Animals; Apolipoprotein A-I; Apolipoproteins A; Apolipopr

1985

Trials

2 trials available for 1-anilino-8-naphthalenesulfonate and Apolipoprotein B-100, Familial Defective

ArticleYear
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy.
    Lipids in health and disease, 2016, Apr-02, Volume: 15

    Topics: Adult; Aged; Anticholesteremic Agents; Drug Therapy, Combination; Epichlorohydrin; Ezetimibe; Female

2016
Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
    Atherosclerosis, 1988, Volume: 72, Issue:2-3

    Topics: Apolipoproteins; Clinical Trials as Topic; Genetic Carrier Screening; Humans; Hypercholesterolemia;

1988

Other Studies

15 other studies available for 1-anilino-8-naphthalenesulfonate and Apolipoprotein B-100, Familial Defective

ArticleYear
[Identification and 3D architecture analysis of the LIPC gene mutation in a pedigree with familial hypercholesterolemia-like phenotype].
    Zhonghua xin xue guan bing za zhi, 2023, Jul-24, Volume: 51, Issue:7

    Topics: Humans; Hyperlipoproteinemia Type II; Lipase; Lipids; Male; Mutation; Pedigree; Phenotype; Proteins

2023
Fenotipo de hipercolesterolemia familiar definitivo con estudio genético negativo en Argentina.
    Archivos de cardiologia de Mexico, 2020, Volume: 90, Issue:2

    Topics: Adult; Aged; Apolipoprotein B-100; Argentina; Female; Genetic Variation; Humans; Hyperlipoproteinemi

2020
Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia.
    Epigenetics, 2014, Volume: 9, Issue:5

    Topics: Adult; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; C

2014
CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Clinical science (London, England : 1979), 2006, Volume: 111, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Cholesterol Ester Transfer Proteins; Coronary Artery Disease; Diseas

2006
A dynamical model of lipoprotein metabolism.
    Bulletin of mathematical biology, 2007, Volume: 69, Issue:4

    Topics: Biological Transport; Humans; Hyperlipoproteinemia Type II; Lipase; Lipoproteins; Models, Biological

2007
The activity of hepatic lipase and lipoprotein lipase in glycogen storage disease: evidence for a circulating inhibitor of postheparin lipolytic activity.
    Pediatric research, 1984, Volume: 18, Issue:9

    Topics: Adult; Child; Chromatography, Affinity; Glycogen Storage Disease Type I; Heparin; Humans; Hyperlipop

1984
[Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Schweizerische medizinische Wochenschrift, 1983, Jun-25, Volume: 113, Issue:25

    Topics: Adolescent; Adult; Apolipoproteins; Arteriosclerosis; Creatinine; Female; Humans; Hyperlipoproteinem

1983
1993 Aspen Cholesterol/Bile Acid Conference: diet and gene interactions in cholesterol metabolism.
    Journal of lipid research, 1994, Volume: 35, Issue:6

    Topics: Animals; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, Dietary; C

1994
Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:2

    Topics: Achilles Tendon; Adolescent; Adult; Calcinosis; Child; Child, Preschool; Coronary Artery Disease; Fe

1997
Testis - a novel storage site in human cholesteryl ester storage disease. Autopsy report of an adult case with a long-standing subclinical course complicated by accelerated atherosclerosis and liver carcinoma.
    Virchows Archiv : an international journal of pathology, 2000, Volume: 436, Issue:1

    Topics: Adult; Arteriosclerosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Choleste

2000
A statistically robust variance-components approach for quantitative trait linkage analysis.
    Annals of human genetics, 1999, Volume: 63, Issue:Pt 3

    Topics: Alleles; Analysis of Variance; Apolipoproteins E; Cholesterol, LDL; Family Health; Gene Frequency; G

1999
Hepatic lipase activity and high density lipoproteins in familial hypercholesterolemia: adaptational mechanisms for LDL-receptor deficient state.
    The Tokai journal of experimental and clinical medicine, 1990, Volume: 15, Issue:6

    Topics: Adaptation, Physiological; Humans; Hyperlipoproteinemia Type II; Lipase; Lipoprotein Lipase; Lipopro

1990
[Primary hyper-high density lipoprotein-cholesterolemia].
    Nihon rinsho. Japanese journal of clinical medicine, 1990, Volume: 48, Issue:11

    Topics: Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipase; Lipoproteins, HDL; Male;

1990
Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia.
    European journal of clinical investigation, 1986, Volume: 16, Issue:1

    Topics: Adult; Aged; Apolipoproteins; Bezafibrate; Cholesterol; Cholesterol, LDL; Female; Humans; Hyperlipop

1986
High density lipoprotein, apoproteins A-I and A-II and postheparin plasma lipolytic enzymes after ileal bypass.
    Atherosclerosis, 1987, Volume: 63, Issue:2-3

    Topics: Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Body Weight; Cholesterol, HDL; Fe

1987